These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17906084)

  • 1. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes.
    Young RP; Hopkins R; Eaton TE
    Eur Respir J; 2007 Oct; 30(4):616-22. PubMed ID: 17906084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing COPD awareness.
    Zielinski J; Bednarek M; Górecka D; Viegi G; Hurd SS; Fukuchi Y; Lai CK; Ran PX; Ko FW; Liu SM; Zheng JP; Zhong NS; Ip MS; Vermeire PA
    Eur Respir J; 2006 Apr; 27(4):833-52. PubMed ID: 16585092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for screening for chronic obstructive pulmonary disease.
    Enright PL; Kaminsky DA
    Respir Care; 2003 Dec; 48(12):1194-201; discussion 1201-3. PubMed ID: 14651760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction?
    Hansen JE; Sun XG; Wasserman K
    Eur Respir J; 2006 Jun; 27(6):1244-50. PubMed ID: 16455822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of a COPD diagnostic questionnaire.
    Kotz D; Nelemans P; van Schayck CP; Wesseling GJ
    Eur Respir J; 2008 Feb; 31(2):298-303. PubMed ID: 17959636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comments on screening spirometry for detection of COPD].
    van den Berg JW; van der Molen T; Kerstjens HA; Quanjer PH
    Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1557-60. PubMed ID: 17715762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
    Stav D; Raz M
    Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD.
    Stratelis G; Mölstad S; Jakobsson P; Zetterström O
    Scand J Prim Health Care; 2006 Sep; 24(3):133-9. PubMed ID: 16923621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
    Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
    Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6.
    Vandevoorde J; Verbanck S; Schuermans D; Kartounian J; Vincken W
    Eur Respir J; 2006 Feb; 27(2):378-83. PubMed ID: 16452596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
    Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
    Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.
    Young RP; Hopkins R; Eaton TE
    Postgrad Med J; 2009 Aug; 85(1006):414-21. PubMed ID: 19633007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spirometry for the diagnosis and management of chronic obstructive pulmonary disease.
    Macintyre NR
    Respir Care; 2009 Aug; 54(8):1050-7. PubMed ID: 19650946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and prevalence of chronic obstructive pulmonary disease in a cardiovascular clinic: evaluation using a hand held FEV₁/FEV₆ meter and questionnaire.
    Wada H; Nakano Y; Nagao T; Osawa M; Yamada H; Sakaguchi C; Matsumoto T; Tsutamoto T; Ito M; Horie M
    Respirology; 2010 Nov; 15(8):1252-8. PubMed ID: 20920134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease.
    Drummond MB; Hansel NN; Connett JE; Scanlon PD; Tashkin DP; Wise RA
    Am J Respir Crit Care Med; 2012 Jun; 185(12):1301-6. PubMed ID: 22561963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
    Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
    Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers.
    Chien JW; Au DH; Barnett MJ; Goodman GE
    COPD; 2007 Dec; 4(4):339-46. PubMed ID: 18027161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.